Around the Web — 3.8.23
The FDA has unveiled its new Dietary Supplement Ingredient Directory, a webpage where the public can look up ingredients used in products marketed as dietary
Michael Posey
March 8, 2023
The FDA has unveiled its new Dietary Supplement Ingredient Directory, a webpage where the public can look up ingredients used in products marketed as dietary
The 2022–23 influenza vaccine has provided reasonable protection against infection and hospitalization caused by infection, members of the CDC’s Advisory Committee on Immunization Practices heard
FDA on Friday granted accelerated approval to sparsentan (Filspari, Travere Therapeutics) to reduce proteinuria in adults with primary IgA nephropathy (IgAN) at risk of rapid
FDA last week approved velmanase alfa (Lamzede), the first enzyme replacement therapy approved in the U.S. for the treatment of non-central nervous system manifestations of alpha-mannosidosis,
Medications approved in the U.S. but not in other countries should be examined closely by health professionals and health systems before use, according to researchers
Of 210 new drugs approved by FDA from 2018 to 2021, 10% had null findings on 1 or more primary efficacy endpoints in pivotal trials,
FDA yesterday approved daprodustat tablets (Jesduvroq, GlaxoSmithKline) as the first oral treatment for anemia caused by chronic kidney disease for adults who have been receiving
FDA has concluded that a new regulatory pathway for cannabidiol (CBD) products is needed that balances individuals’ desire for access to CBD products with the
FDA has issued a final guidance, “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Guidance for Industry.” This guidance provides the FDA’s current thinking on
The 37 new chemical/biological entities approved by FDA during 2022 are discussed in an FDA Voices article published this week. Written by Patrizia Cavazzoni, director